Chinese expert consensus on the combined use of antiviral drugs for influenza

Influenza is an acute respiratory infectious disease caused by influenza viruses, and it poses a serious threat to global public health. High-risk groups include the elderly, infants and young children, pregnant women, and patients with chronic underlying diseases. These groups are prone to developing severe illness after infection, which can lead to serious complications and even death. Early antiviral treatment is key to reducing the rate of severe illness and death. Currently, authoritative guidelines at home and abroad recommend early, single-agent antiviral therapy as the standard regimen. However, anti-influenza virus monotherapy has problems such as drug resistance and poor therapeutic effect. To address these problems, this consensus was developed by organizing experts from the departments of Infectious Diseases, Respiratory Medicine, Critical Care Medicine, and Pharmacy. These experts systematically sorted out domestic and international evidence on combined antiviral therapy for influenza and formulated expert recommendations on combined antiviral therapy for influenza in specific populations.

Authors

Institutions

Publication Details

Journal
BioScience Trends
Published
2025-10-28
DOI
https://doi.org/10.5582/bst.2025.01292
Citations
2
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chinese expert consensus on the combined use of antiviral drugs for influenza

Linghua Li, Rongrong Zou, Bingliang Lin, Jianning Jiang et al.
2 citations
BioScience Trends
Influenza Virus Research Studies
2.71
article

Chinese expert consensus on the combined use of antiviral drugs for influenza

Linghua Li, Rongrong Zou, Bingliang Lin, Jianning Jiang, Bo Qin, Yutian Chong, Zhijun Qu, Wen‐Jun Gao, Weizhen Weng, Haipeng Zhu, Jia Huang, Zuojiong Gong, Kaijin Xu, Guanlin Zhou, Feng Xu, Fei Shi, Jiang Rongmeng, Yongshui Fu, Cheng-hui Huang, Juan Xu, He Huang, Xilong Deng, Haimei Zhang, Fei Xiao, Jing Yuan, Lingwei Wang, Liang Fu, Tao Wu, Yan Wang, Xi Liu, Hui Wang, Jie Peng, Hongzhou Lu, Feng Lin, Guangbin Chen, Gang Wu, Yongfang Jiang, Jun Chen, H. X. Bai, Qingsong Qi
article en
2 citations

Abstract

Influenza is an acute respiratory infectious disease caused by influenza viruses, and it poses a serious threat to global public health. High-risk groups include the elderly, infants and young children, pregnant women, and patients with chronic underlying diseases. These groups are prone to developing severe illness after infection, which can lead to serious complications and even death. Early antiviral treatment is key to reducing the rate of severe illness and death. Currently, authoritative guidelines at home and abroad recommend early, single-agent antiviral therapy as the standard regimen. However, anti-influenza virus monotherapy has problems such as drug resistance and poor therapeutic effect. To address these problems, this consensus was developed by organizing experts from the departments of Infectious Diseases, Respiratory Medicine, Critical Care Medicine, and Pharmacy. These experts systematically sorted out domestic and international evidence on combined antiviral therapy for influenza and formulated expert recommendations on combined antiviral therapy for influenza in specific populations.

BioScience TrendsVol. 19(5)
Central South University (CN), Sun Yat-sen University (CN), Guangxi Medical University (CN), Shanghai Jiao Tong University (CN), Capital Medical University (CN), Peking University (CN), Ruijin Hospital (CN), Wuhan University (CN), Affiliated Hospital of Southwest Medical University (CN), Longgang Central Hospital (CN), Ganzhou People's Hospital (CN), Zhongshan City Second People's Hospital (CN), ShenZhen People’s Hospital (CN), First People's Hospital of Foshan (CN), Shanghai Public Health Clinical Center (CN), Fifth Affiliated Hospital of Sun Yat-sen University (CN), Dongguan People’s Hospital (CN), First Affiliated Hospital of GuangXi Medical University (CN), Hainan General Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Peking University First Hospital (CN), Shenzhen Bao'an District People's Hospital (CN), Renmin Hospital of Wuhan University (CN), Third Affiliated Hospital of Sun Yat-sen University (CN), Beijing Ditan Hospital (CN), Second Xiangya Hospital of Central South University (CN), Guangzhou Eighth People's Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Shenzhen Second People's Hospital (CN), Shenzhen Third People’s Hospital (CN), First Affiliated Hospital Zhejiang University (CN), Southern Medical University (CN), Chongqing Medical University (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 8%
Influenza Virus Research Studies
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.